G3 Global Berhad Valuation

Is G3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of G3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate G3's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate G3's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for G3?

Key metric: As G3 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for G3. This is calculated by dividing G3's market cap by their current revenue.
What is G3's PS Ratio?
PS Ratio	1x
Sales	RM 91.31m
Market Cap	RM 94.34m

G3 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.8x
Enterprise Value/EBITDA	-17.6x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does G3's PS Ratio compare to its peers?

The above table shows the PS ratio for G3 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.6x
UMC UMediC Group Berhad	4.1x	18.9%	RM 226.2m
PHARMA Pharmaniaga Berhad	0.1x	1.9%	RM 511.6m
HONGSENG Hong Seng Consolidated Berhad	5.1x	n/a	RM 76.6m
SMILE Smile-Link Healthcare Global Berhad	1x	n/a	RM 32.8m
G3 G3 Global Berhad	1x	n/a	RM 94.3m

Price-To-Sales vs Peers: G3 is good value based on its Price-To-Sales Ratio (1x) compared to the peer average (2.6x).

Price to Sales Ratio vs Industry

How does G3's PS Ratio compare vs other companies in the Asian Healthcare Industry?

62 Companies	Price / Sales	Estimated Growth	Market Cap

62 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: G3 is good value based on its Price-To-Sales Ratio (1x) compared to the Asian Healthcare industry average (1.6x).

Price to Sales Ratio vs Fair Ratio

What is G3's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

G3 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	1x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate G3's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.